The invention relates to compounds of the general formula (I), in which R1, R2, R3, R4, R5, R6 and X are as defined in Claim 1. These compounds can be used in the treatment of pathologies associated with insulin resistance syndrome.
本发明涉及一般式(I)的化合物,其中R1、R2、R3、R4、R5、R6和X如权利要求书中所定义。这些化合物可用于治疗与
胰岛素抵抗综合征相关的病理生理学。